Anbio Biotechnology (NNNN)

NASDAQ: NNNN · Real-Time Price · USD

26.60

-0.55 (-2.03%)

Apr 20, 2026, 3:14 PM EDT - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Surgical & Medical Equipment	8.65M	8.19M	6.71M	23.54M	4.43M
Surgical & Medical Equipment Growth	5.64%	21.95%	-71.49%	431.67%	-
Total	8.65M	8.19M	6.71M	23.54M	4.43M
Total Growth	5.64%	21.95%	-71.49%	431.67%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
European Union	5.15M	5.62M	4.66M	20.30M	4.09M
European Union Growth	-8.31%	20.54%	-77.04%	396.27%	-
Asia Pacific	1.52M	509.17K	73.40K	3.19M	-
Asia Pacific Growth	198.61%	593.74%	-97.70%	-	-
North America	296.20K	110.51K	215.44K	50.00K	337.50K
North America Growth	168.03%	-48.71%	330.87%	-85.19%	-
South America	269.54K	1.48M	1.65M	-	-
South America Growth	-81.73%	-10.68%	-	-	-
Other Regions	1.41M	472.38K	111.05K	-	-
Other Regions Growth	198.40%	325.38%	-	-	-
Total	8.65M	8.19M	6.71M	23.54M	4.43M
Total Growth	5.64%	21.95%	-71.49%	431.67%	-

Source: S&P Global Market Intelligence.